CORRECTIVE- bismuth subsalicylate suspension
Phoenix Pharmaceutical Inc./ Clipper Distributing, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

INDICATIONS

For oral administration as an aid in the treatment of noninfectious diarrhea in horses, cattle, dogs and cats.

DOSAGE

Cattle 6 - 10 oz. Every 2 - 3 hours
Calves 3 - 4 oz. Every 2 - 3 hours
Horses 6 - 10 oz. Every 2 - 3 hours
Foals 3 - 4 oz. Every 2 - 3 hours
Dogs 1 - 3 Tbls. (1/2 - 2 oz.) Every 1 - 3 hours
Cats 1 - 3 Tbls. (1/2 - 2 oz.) Every 1 - 3 hours

WARNING

If symptoms persist after using this product for 2 to 3 days consult a veterinarian.

FOR ANIMAL USE ONLY
NOT FOR HUMAN USE

CONTAINS:

Bismuth Subsalicylate ........... 1.75%

Administration: Oral.

SHAKE WELL BEFOR USING.
KEEP FROM FREEZING.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

TAKE TIME OBSERVE LABEL DIRECTIONS

Manufactured For:
Phoenix Pharmaceutical, Inc.
St. Joseph, MO 64503

Package/Label Principal Display Panel

NDC 57319-393-09

Corrective Suspension
Anti-Diarrheal Suspension

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

Net Contents: 3.785 L (1 Gal.)

Manufactured For:
Phoenix Pharmaceutical, Inc.
St. Joseph, MO 64503

Manufactured by:
Ameri-Pac
St. Joseph, MO 64502

Bottle Label

CORRECTIVE
bismuth subsalicylate suspension

Product Information
Product Type	OTC ANIMAL DRUG	Item Code (Source)	NDC:57319-393
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BISMUTH SUBSALICYLATE (BISMUTH CATION)	BISMUTH SUBSALICYLATE	18 mg in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER
GUAR GUM
METHYL SALICYLATE
POTASSIUM SORBATE
SACCHARIN SODIUM
D&C RED NO. 33
SILICON DIOXIDE

Product Characteristics
Color		Score
Shape		Size
Flavor	WINTERGREEN	Imprint Code
Contains

Packaging
#	Item Code	Package Description
1	NDC:57319-393-09	3785 mL in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		04/20/2000

Labeler - Phoenix Pharmaceutical Inc./ Clipper Distributing, Inc. (150711039)

Revised: 03/2013

Document Id: 3d1c67bf-21ef-44f9-b0b3-2e8be0c5fd7d

Set id: 3d1c67bf-21ef-44f9-b0b3-2e8be0c5fd7d

Version: 1

Effective Time: 20130308

Phoenix Pharmaceutical Inc./ Clipper Distributing, Inc.